Besilesomab for imaging inflammation and infection in peripheral bone in adults with suspected osteomyelitis

Reports in Medical Imaging

Volumn 3, Issue 1, 2010, Pages 17-27

  Blazeski, Adriana ^a   Kozloff, Kenneth M ^a,b   Scott, Peter J H ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

99mTc scintigraphy; Bone infection; BW 250 183; Radiolabeled monoclonal antibodies; Scintimun

Indexed keywords

ALBUMIN TC 99M; ANTIMONY TECHNETIUM SULFIDE TC 99M; BESILESOMAB TC 99M; BW 250 183; COLLOID TC 99M; DIAGNOSTIC AGENT; ETIDRONIC ACID TC 99M; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; LEUKOCYTE IN 111; LEUKOCYTE TC 99M; MEDRONATE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY BW 250 183; MONOCLONAL ANTIBODY TC 99M; NANOCOLL TC 99M; NANOCOLLOID TC 99M; NCA 95; RADIOPHARMACEUTICAL AGENT; SULESOMAB TC 99M; UNCLASSIFIED DRUG;

ADULT; BONE INFECTION; BONE SCINTISCANNING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; DOSIMETRY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; HUMAN; NONHUMAN; OSTEITIS; OSTEOMYELITIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNSPECIFIED SIDE EFFECT;

EID: 78649786398     PISSN: None     EISSN: 11791586     Source Type: Journal    
DOI: 10.2147/RMI.S9458     Document Type: Review

References (89)

1. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364:369-379.
2. Jauregui LE, Senour CL. Chronic osteomyelitis. In: Jauregui LE, editor. Diagnosis and Management of Bone Infections. New York, NY: Marcel Dekker; 1995:37-108.
3. Waldvogel FA, Papageorgiou PS. Osteomyelitis: the past decade. N Engl J Med. 1980;303:360-370.
4. Calhoun J, Manring M. Adult osteomyelitis. Infect Dis Clin North Am. 2005;19:765-786.
5. Kaplan S. Osteomyelitis in children. Infect Dis Clin North Am. 2005;19:787-797.
6. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997;336:999-1007.
7. Esposito S, Leone S, Bassetti M, et al. Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection. 2009;6:478-496.
8. Hartemann-Heurtier A, Senneville E. Diabetic foot osteomyelitis. Diabetes Metab. 2008;34:87-95.
9. Prandini N, Lazzeri E, Rossi B, Erba P, Parisella MG, Signore A. Nuclear medicine imaging of bone infections. Nucl Med Commun. 2006;27:633-644.
10. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med. 1970;282:316-322.
11. Cierny G, Mader JT, Pennick JJ. A clinical staging system for adult osteomyelitis. Contemp Orthop. 1985;10:17-37.
12. Ciampolini J, Harding KJ. Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad Med J. 2000;76:479-483.
13. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol. 2008;52:13-22.
14. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am. 2004;86:2305-2318.
15. Mackowiack PA, Jones SR, Smith JW. Diagnostic value of sinus- tract cultures in chronic osteomyelitis. JAMA. 1978;239:2772-2775.
16. Perry CR, Pearson RL, Miller GA. Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the properative assessment of osteomyelitis. J Bone Joint Surg Am. 1991;73:745-749.
17. Haas DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med. 1996;101:550-561.
18. Mader JT, Shirtliff ME, Bergquist SC, Calhoun J. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res. 1999;360:47-65.
19. Seabold JE, Flickinger FW, Kao SCS, et al. Indium-111-leukocyte/technetium- 99m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med. 1990;31:549-556.
20. Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA. Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods. Chem Rev. 2010;110:3112-3145.
21. Sammak B, Bagi MAE, Shahed MA, et al. Osteomyelitis: a review of currently used imaging techniques. Eur Radiol. 1999;9:894-900.
22. Pineda C, Vargas A, Rodriguez AV. Imaging osteomyelitis: current concepts. Infect Dis Clin North Am. 2006;20:789-825.
23. Marshall D, Haskard DO. Quantifying inflammation in vivo using radiolabeled antibodies and leukocytes. In: Winyard PG, Willonghby DA, editors. Methods in Molecular Biology. Vol 225: Inflammation Protocols; 2003. p. 273-282.
24. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med. 1994;24:142-153.
25. Walker RC, Jones-Jackson LB, Martin W, Habibian MR, Delbeke D. New imaging tools for the diagnosis of infection. Future Microbiol. 2007;2:527-554.
26. Albiri MM, Kirpekar M, Ablow RC. Osteomyelitis: detection with US. Radiology. 1989;172:509-514.
27. Robben SG. Ultrasonography of musculoskeletal infections in children. Eur Radiol. 2004;14 Suppl 4:L65-L77.
28. Fayad LM, Carrino JA, Fishman EK. Musculoskeletal infection: role of CT in the emergency department. Radiographics. 2007;27:1723-1736.
29. Kaim A, Ledermann HP, Bongartz G, Messmer P, Müller-Brand J, Steinbrich W. Chronic post-traumatic osteomyelitis of the lower extremity: comparison of magnetic resonance imaging and combined bone scintigraphy/immunoscintigraphy with radiolabelled monoclonal antigranulocyte antibodies. Skeletal Radiol. 2000;29:378-386.
30. Unger E, Moldofsky P, Gatenby R, Hartz W, Broder G. Diagnosis of osteomyelitis by MR imaging. Am J Roentgenol. 1988;150:605-610.
31. Fletcher BD, Scoles PV, Nelson AD. Osteomyelitis in children: detection by magnetic resonance. Radiology. 1984;150:57-60.
32. Tehranzadeh J. Magnetic resonance imaging of osteomyelitis. Crit Rev Diagn Imaging. 1992;33:495-534.
33. Locher JT. Labelled monoclonal antibodies used for detection of inflammatory processes and bone marrow metastases. Nucl Med Rev. 2001;4:129-135.
34. Graute V, Feist M, Lehner S, Bartenstein P, Hacker M. Detection of low-grade joint infections using 99mTc-antigranulocyte SPECT/CT: initial clinical results. J Nucl Med. 2010;51 Suppl 2:1630.
35. Brugen Wvd, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJG. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med. 2010;40:3-15.
36. Linke R, Kuwert T, Uder M, Forst R, Wuest W. Skeletal SPECT/CT of the peripheral extremities. Am J Roentgenol. 2010;194:W329-W335.
37. Palestro CJ. In vivo leukocyte labeling: the quest continues. J Nucl Med. 2007;48:332-334.
38. Palestro CJ, Love C, Schneider R. The evolution of nuclear medicine and the musculoskeletal system. Radiol Clin North Am. 2009;47:505-532.
39. Gross T, Kaim AH, Regazzoni P, Widmer AF. Current concepts in posttraumatic osteomyelitis: a diagnostic challenge with new imaging options. J Trauma. 2002;52:1210-1219.
40. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25:1357-1368.
41. Kaim AH, Gross T, Schulthess GK. Imaging of chronic posttraumatic osteomyelitis. Eur Radiol. 2002;12:1193-1202.
42. Kumar R, Basu S, Torigian D, Anand V, Zhuang H, Alavi A. Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev. 2008;21:209-224.
43. Kälicke T, Schmitz J, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med. 2000;27:524-528.
44. Schmitz A, Risse HJ, Källicke T, Grünwald F, Schmitt O. FDG-PET for diagnosis and follow-up of inflammatory processes: initial results from the orthopedic viewpoint. Z Orthop Ihre Grenzgeb. 2000;138:407-412.
45. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47-59.
46. Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med. 2000;25:281-284.
47. Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m Antigranulocyte Antibody Scintigraphy in Chronic Osteomyelitis. J Nucl Med. 1998;39:2145-2152.
48. Heiba SI, Luo J, Sadek S, et al. Attenuation correction induced artifact in F-18 FDG PET imaging following total knee replacement. Clin Positron Imaging. 2000;3:237-239.
49. Zhuang H, Duarte PS, Pourdehnad M, et al. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med. 2001;42:44-48.
50. Palestro CJ, Love C. Radionuclide imaging of musculoskeletal infection: conventional agents. Semin Musculoskelet Radiol. 2007;11:335-352.
51. Richter WS, Humplik BI. Monoclonal antibody BW 270/183 (Scintimun' Granulocyte) for scintigraphic imaging of infection/inflammation and detection of bone marrow metastases: review of the literature. Newsletter of the International Society of Radiolabeled Blood Elements. 2004;10:5-9.
52. Becker W. The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med. 1995;22:1195-1211.
53. Kalin B, Axelsson B, Jacobsson H. Quantitative evaluation of four 99mTc colloids for bone marrow scintigraphy using single photon emission computed tomography. Nucl Med Commun. 1991;12:135-145.
54. Flivik G, Sloth M, Rydholm U, Herrlin K, Lidgren L. Technetium- 99m-nanocolloid scintigraphy in orthopedic infections: a comparison with indium-111-labeled leukocytes. J Nucl Med. 1993;34:1646-1650.
55. Papós M, Barát F, Nárai G, Dillmann J, Láng J, Csernay L. Tc-99m HMPAO leukocyte and Tc-99m nanocolloid scintigraphy in posttraumatic bone infection. Clin Nucl Med. 1998;23:423-428.
56. Ang ES, Sundram FX, Goh ASW, Aw SE. 99mTc-polyclonal IgG and 99mTc nanocolloid scans in orthopaedics: a comparison with conventional bone scan. Nucl Med Commun. 1993;14:419-432.
57. Ooi GC, Belton I, Finlay D. Comparison of technetium 99m nanocolloid and indium 111 leucocytes in the diagnosis of orthopaedic infections. Br J Radiol. 1993;66:1025-1030.
58. Dutton JAE, Bird NJ, Skehan SJ, Peters AM. Evaluation of a 3-hour indium 111 leukocyte image as a surrogate for a technetium-99m nanocolloid marrow scan in the diagnosis of orthopedic infection. Clin Nucl Med. 2004;29:469-474.
59. European Medicines Agency. Assessment report for Scintimun (International Nonproprietary Name: besilesomab). 2009;Doc. Ref. EMEA/743339/2009:Procedure No. EMEA/H/C/001045.
60. Joseph K, Höffken H, Bosslet K, Schorlemmer U. In vivo labelling of granulocytes with Tc-99m-anti-NCA monoclonal antibodies for imaging inflammation. Eur J Nucl Med. 1988;14:367-373.
61. Bosslet K, Steinsträesser A, Schwarz A. Generation and functional characteristics of the granulocyte selective monoclonal antibody BW250/183. Nukl Med. 1989;28:148-159.
62. Hotze AL, Briele B, Overbeck B, et al. Technetium-99m-labeled anti-granulocyte antibodies in suspected bone infections. J Nucl Med. 1992;33:526-531.
63. Horger M, Eschmann SM, Pfannenberg C, et al. The value of SPET/ CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging. 2003;30:1665-1673.
64. Reuland P, Winker KH, Heuchert T, et al. Detection of infection in postoperative orthopedic patients wiith technetium-99m-labeled monoclonal antibodies against granulocytes. J Nucl Med. 1991;32:2209-2214.
65. Kaim A, Maurer T, Ochsner P, Jundt G, Kirsch E, Mueller-Brand J. Chronic complicated osteomyelitis of the appendicular skeleton: diagnosis with technetium-99m labelled monoclonal antigranulocyte antibody-immunoscintigraphy. Eur J Nucl Med. 1997;24:732-738.
66. Sciuk J, Brandau W, Vollet B, et al. Comparison of technetium 99m polyclonal human immunoglobulin and technetium 99m monoclonal antibodies for imaging chronic osteomyelitis. Eur J Nucl Med. 1991;18:401-407.
67. Rüther W, Hotze A, Möller F, Bockisch A, Heitzmann P, Biersack HJ. Diagnosis of bone and joint infection by leucocyte scintigraphy. A comparative study with 99mTc-HMPAO-labelled leucocytes, 99mTclabelled antigranulocyte antibodies and 99mTc-labelled nanocolloid. Arch Othop Trauma surg. 1990;110:26-32.
68. Seybold K, Frey LD, Locher J. Immunoscintigraphy of infections using 123I and 99mTc-labeled monoclonal antibodies. Advanced experiences in 230 patients. Angiology. 1992;43:85-90.
69. Gallowitsch HJ, Heinisch M, Mikosch P, et al. Tc-99m ciprofloxacin in clinically selected patients suspected for peripheral osteomyelitis, spondylodiscitis and fever of unknown origin: preliminary results. Nuklearmedizin. 2002;41:30-36.
70. Peltier P, Potel G, Lovat E, Baron D, Chatal JF. Detection of lung and bone infection with antigranulocyte monoclonal antibody BW 250/183 radiolabelled with 99Tcm. Nucl Med Commun. 1993;14:766-774.
71. Gratz S, Behr T, Herrmann A, et al. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc- HMPAO labelled white blood cells for the imaging of infection. Eur J Nucl Med. 1998;25:386-393.
72. Kroiss A, Böck F, Perneczky G, et al. Immunszintigraphie zur aufdeckung von Entündungsherden bei knochen- und gelenkserkrankungen. Wien Klin Wochenschr. 1990;102:713-717.
73. Gratz S, Höffken H, Kaiser JW, behr TM, Strosche H, Reize P. Nuklearmedizinische diagnostik bei schmerzhafter knieprothese. Der Radiologe. 2009;49:59-67.
74. Bleeker-Rovers CP, Vos FJ, Corstens FHM. Scintigraphic detection of infection and inflammation. In: Biersack HJ, Freeman LM, editors. Clinical Nuclear Medicine. Berlin, Germany: Springer; 2007:347-359.
75. Palestro CJ. Radionuclide imaging of infection: what the future holds. Braz Archiv Biol Technol 2008;51(spe):1-5.
76. Pakos EE, Koumoulis HD, Fotopoulos AD, Loannidis JPA. Osteomyelitis: antigranulocyte scintigraphy with 99mTc radiolabeled monoclonal antibodies for diagnosis: meta analysis. Radiology. 2007;245:732-741.
77. Lind P, Langsteger W, Költringer P, Dimai HP, Passl R, Eber O. Immunoscintigraphy of inflammatory processes with a technetium- 99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med. 1990;31:417-423.
78. Dominguez-Gadea L, Martin-Curto LM, de la Calle H, Crespo A. Diabetic foot infections: scintigraphic evaluation with 99mTc-labeled anti-granulocyte antibodies. Nucl Med Commun. 1993;14:212-218.
79. Schwegler B, Stumpe KDM, Weishaupt D, et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. J Int Med. 2007;263:99-106.
80. Becker W, Dölkemeyer U, Gramatzki M, Schneider MU, Scheele J, Wolf F. Use of immunoscintigraphy in the diagnosis of fever of unknown origin. Eur J Nucl Med. 1993;20:1078-1083.
81. Segarra I, Roca M, Baliellas C, et al. Granulocyte-specific monoclonal antibody technetium-99m-BW 250/183 and indium-111 oxine-labelled leucocyte scintigraphy in inflammatory bowel disease. Eur J Nucl Med. 1991;18:715-719.
82. Mahida YR, Perkins AC, Frier M, Wastie ML, Hawkey CJ. Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report. Nucl Med Commun. 1992;13:330-335.
83. Stathaki MI, Koukouraki SI, Karkavitsas NS, Koutroubakis IE. Role of scintigraphy in inflammatory bowel diseaase. World J Gastroenterol. 2009;15:2693-2700.
84. Klett R, Kordelle J, Stahl U, et al. Immunoscintigraphy of septic loosening of knee endoprosthesis: a retrospective evaluation of the antigranulocyte antibody BW 250/183. Eur J Nucl Med Mol Imaging. 2003;30:1463-1466.
85. Boubaker A, Delaloye AB, Blanc CH, Dutoit M, Leyvraz PF, Delaloye B. Immunoscintigraphy with antigranulocyte monoclonal antibodies for the diagnosis of septic loosening of hip prostheses. Eur J Nucl Med. 1995;22:139-1347.
86. Duncker CM, Carrió I, Berná L, et al. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med. 1990;31:1450-1455.
87. Sohn SK, Ahn BC, Lee SW, et al. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma. Eur J Nucl Med. 2002;29:591-596.
88. Buchmann I, Kull T, Glatting G, et al. A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy. Eur J Nucl Med Mol Imaging. 2003;30:667-673.
89. Wuest W, Kuwert T, Grunewald M, et al. Skeletal SPECT/CT of the peripheral extremities: interdisciplinary approach in orthopaedic disorders - first clinical results. Cent Eur J Med. 2007;2:499-510.